Drug Shortage Report for PMSC-ESCITALOPRAM
Report ID | 6331 |
Drug Identification Number | 02303965 |
Brand name | PMS-ESCITALOPRAM |
Common or Proper name | ESCITALOPRAM |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-04-09 |
Estimated end date | Unknown |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | Product to be discontinued - relaunch under other DINS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-06-10 | French | Compare |
v3 | 2020-06-10 | English | Compare |
v2 | 2017-04-10 | French | Compare |
v1 | 2017-04-10 | English | Compare |
Showing 1 to 4 of 4